|
1
|
Khan F, Rahman A and Carrier M: Occult
cancer detection in venous thromboembolism: The past, the present,
and the future. Res Pract Thromb Haemost. 1:9–13. 2017. View Article : Google Scholar
|
|
2
|
Davari M, Amani B, Mokarian F, Hoseini M,
Akbarzadeh A and Heidarzadeh Khoramabadi N: Effectiveness of
trastuzumab as adjuvant therapy in patients with early stage breast
cancer: A systematic review and meta-analysis. Med J Islam Repub
Iran. 31:882017. View Article : Google Scholar
|
|
3
|
Peart O: Metastatic breast cancer. Radiol
Technol. 88:519M–539M. 2017.PubMed/NCBI
|
|
4
|
Tian T, Wang M, Lin S, Guo Y, Dai Z, Liu
K, Yang P, Dai C, Zhu Y, Zheng Y, et al: The impact of lncRNA
dysregulation on clinicopathology and survival of breast cancer: A
systematic review and meta-analysis. Mol Ther Nucleic Acids.
12:359–369. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shamsi M and Pirayesh Islamian J: Breast
cancer: Early diagnosis and effective treatment by drug delivery
tracing. Nucl Med Rev Cent East Eur. 20:45–48. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hammerl D, Smid M, Timmermans AM, Sleijfer
S, Martens JWM and Debets R: Breast cancer genomics and
immuno-oncological markers to guide immune therapies. Semin Cancer
Biol. 52:178–188. 2018. View Article : Google Scholar
|
|
7
|
Walker-Smith TL and Peck J: Genetic and
genomic advances in breast cancer diagnosis and treatment. Nurs
Womens Health. 23:518–525. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng JM, Kong YY, Li YY and Zhang W:
MagT1 regulated the odontogenic differentiation of BMMSCs induced
byTGC-CM via ERK signaling pathway. Stem Cell Res Ther. 10:482019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goytain A and Quamme GA: Identification
and characterization of a novel mammalian Mg2+
transporter with channel-like properties. BMC Genomics. 6:482005.
View Article : Google Scholar
|
|
10
|
Chaigne-Delalande B, Li FY, O'Connor GM,
Lukacs MJ, Jiang P, Zheng L, Shatzer A, Biancalana M, Pittaluga S,
Matthews HF, et al: Mg2+ regulates cytotoxic functions
of NK and CD8 T cells in chronic EBV infection through NKG2D.
Science. 341:186–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang G, Li Y, Li J, Zhang D, Luo C, Zhang
B and Sun X: microRNA-199a-5p suppresses glioma progression by
inhibiting MAGT1. J Cell Biochem. 120:15248–15254. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng K, Yang Q, Xie L, Qiu Z, Huang Y,
Lin Y, Tu L and Cui C: Overexpression of MAGT1 is associated with
aggressiveness and poor prognosis of colorectal cancer. Oncol Lett.
18:3857–3862. 2019.PubMed/NCBI
|
|
13
|
Philipsen S and Suske G: A tale of three
fingers: The family of mammalian Sp/XKLF transcription factors.
Nucleic Acids Res. 27:2991–3000. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaczynski J, Cook T and Urrutia R: Sp1-
and Kruppel-like transcription factors. Genome Biol. 4:2062003.
View Article : Google Scholar
|
|
15
|
Sun N, Shen C, Zhang L, Wu X, Yu Y, Yang
X, Yang C, Zhong C, Gao Z, Miao W, et al: Hepatic Krüppel-like
factor 16 (KLF16) targets PPARα to improve steatohepatitis and
insulin resistance. Gut. 70:2183–2195. 2021. View Article : Google Scholar
|
|
16
|
Yang X, Chen Q, Sun L, Zhang H, Yao L, Cui
X, Gao Y, Fang F and Chang Y: KLF10 transcription factor regulates
hepatic glucose metabolism in mice. Diabetologia. 60:2443–2452.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cui A, Fan H, Zhang Y, Zhang Y, Niu D, Liu
S, Liu Q, Ma W, Shen Z, Shen L, et al: Dexamethasone-induced
Krüppel-like factor 9 expression promotes hepatic gluconeogenesis
and hyperglycemia. J Clin Invest. 129:2266–2278. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma P, Sun CQ, Wang YF, Pan YT, Chen QN,
Liu WT, Liu J, Zhao CH, Shu YQ and Li W: KLF16 promotes
proliferation in gastric cancer cells via regulating p21 and CDK4.
Am J Transl Res. 9:3027–3036. 2017.PubMed/NCBI
|
|
19
|
Bang S, Li J, Zhang M, Cui R, Wu X, Xin Z,
Ma D, Zhang J and Zhang H: The clinical relevance and function of
Krüppel-like factor 16 in breast cancer. Cancer Manag Res.
12:6373–6383. 2020. View Article : Google Scholar :
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Harbeck N and Gnant M: Breast cancer.
Lancet. 389:1134–1150. 2017. View Article : Google Scholar
|
|
22
|
Kozlowski J, Kozłowska A and Kocki J:
Breast cancer metastasis-insight into selected molecular mechanisms
of the phenomenon. Postepy Hig Med Dosw (Online). 69:447–451. 2015.
View Article : Google Scholar
|
|
23
|
Osborne C, Wilson P and Tripathy D:
Oncogenes and tumor suppressor genes in breast cancer: Potential
diagnostic and therapeutic applications. Oncologist. 9:361–377.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sung NJ, Kim NH, Surh YJ and Park SA:
Gremlin-1 promotes metastasis of breast cancer cells by activating
STAT3-MMP13 signaling pathway. Int J Mol Sci. 21:92272020.
View Article : Google Scholar :
|
|
25
|
Li J, Guo Y, Duan L, Hu X, Zhang X, Hu J,
Huang L, He R, Hu Z, Luo W, et al: AKR1B10 promotes breast cancer
cell migration and invasion via activation of ERK signaling.
Oncotarget. 8:33694–33703. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
de Baaij JH, Hoenderop JG and Bindels RJ:
Magnesium in man: Implications for health and disease. Physiol Rev.
95:1–46. 2015. View Article : Google Scholar
|
|
27
|
Li H, Xia T, Guan Y and Yu Y: Sevoflurane
regulates glioma progression by Circ_0002755/miR-628-5p/MAGT1 axis.
Cancer Manag Res. 12:5085–5098. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bi C, Zhang X, Chen Y, Dong Y, Shi Y, Lei
Y, Lv D, Cao X, Li W and Shi H: MAGT1 is required for HeLa cell
proliferation through regulating p21 expression, S-phase progress
and ERK/p38 MAPK MYC axis. Cell Cycle. 20:2233–2247. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Di Giammartino DC: Kloetgen A, Polyzos A,
Liu Y, Kim D, Murphy D, Abuhashem A, Cavaliere P, Aronson B, Shah
V, et al KLF4 is involved in the organization and regulation of
pluripotency-associated three-dimensional enhancer networks. Nat
Cell Biol. 21:1179–1190. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lambert M, Jambon S, Depauw S and
David-Cordonnier MH: Targeting transcription factors for cancer
treatment. Molecules. 23:14792018. View Article : Google Scholar :
|
|
31
|
Yadav RK, Chauhan AS, Zhuang L and Gan B:
FoxO transcription factors in cancer metabolism. Semin Cancer Biol.
50:65–76. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yeung SJ, Pan J and Lee MH: Roles of p53,
MYC and HIF-1 in regulating glycolysis-the seventh hallmark of
cancer. Cell Mol Life Sci. 65:3981–3999. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Viatour P, Merville MP, Bours V and
Chariot A: Phosphorylation of NF-kappaB and IkappaB proteins:
Implications in cancer and inflammation. Trends Biochem Sci.
30:43–52. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shields JM and Yang VW: Identification of
the DNA sequence that interacts with the gut-enriched Krüppel-like
factor. Nucleic Acids Res. 26:796–802. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Miller IJ and Bieker JJ: A novel,
erythroid cell-specific murine transcription factor that binds to
the CACCC element and is related to the Krüppel family of nuclear
proteins. Mol Cell Biol. 13:2776–2786. 1993.PubMed/NCBI
|
|
36
|
Chen X, Li S, Ke Y, Wu S, Huang T, Hu W,
Fu H and Guo X: KLF16 suppresses human glioma cell proliferation
and tumourigenicity by targeting TFAM. Artif Cells Nanomed
Biotechnol. 46(Suppl 1): S608–S615. 2018. View Article : Google Scholar
|
